📉Record unemployment in the US -an opportunity to earn IPO ACCD🔎 Hello everyone! We have an interesting trading idea for you - how you can earn 50% or more on the exchange by participating in the initial placement of Accolade shares (ACCD). Accolade is a startup that has developed a healthcare platform for employers. The company's platform helps its users better navigate the healthcare system, as well as reduce costs for medical purposes. As you know, due to COVID-19, many companies now suffer huge costs and strive to optimize their performance as best as possible. By the way, unemployment in the US is now at a record level, which has not been recorded since the great depression (1929-1939) - see the chart.
ACC Accolade uses a range of technologies - from machine learning to mobile apps-to make it easier for employees to access medical care. Employers are charged a subscription fee depending on the number of employees. The volume of investments attracted by the company, according to crunchabase, amounts to $237.3 million. In addition, Accolade has bought the company and konciergeMD MD Insider. You can see the picture of the business structure of this company below.
🤝 If you need statistics on the company's financial performance, you can write to me and I will send you a detailed report. If you do not know how to perform the operation and start from 25,000 rubles, you can also write to me, I will help you, but the deadline is 20-00 today in Moscow. Opportunities appear quickly and disappear just as quickly. I expect the return on this IPO to be around + 50% or higher, but I remind you that there is a risk of losing all or part of your capital, so invest no more than what you are prepared to lose.
📈 Graphs will be in the comments, so that the article is not blocked
IPO
$API is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Agora offers a suite of voice and video application programming interfaces.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $45,00;
take-profit — $67,95;
stop-loss — $37,59.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$AKUS is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Akouos creates a precision genetic medicine platform to develop AAV-delivered gene therapies for various types of hearing loss.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $23,00;
take-profit — $19,17;
stop-loss — $33,21.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Recent IPO + hot sector! Quiet period ending Jun 30thIndependent payment processing and financial technology company
Lead:Citigroup, Credit Suisse, Goldman Sachs
Co manager: BofA Securities, Morgan Stanley, RBC Capital Markets, Evercore ISI, Raymond James, Suntrust Robinson Humphrey, Wolfe Capital, TD Securities, Telsey Advisory Group
$GTH is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Genetron Holdings Limited operates as a biology company. The Company develops treatment for cancer. Genetron Holdings serves customers in China.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $17,00;
take-profit — $21,80;
stop-loss — $15,40.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$FMTX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $43,24;
take-profit — $57,88;
stop-loss — $38,36.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$RPRX is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $45,18;
take-profit — $54,12;
stop-loss — $42,20.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
BNR is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Burning Rock Biotech Limited focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $24,54;
take-profit — $32,74;
stop-loss — $21,82.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
RNA is giving a GREAT IPO LONG opportunity today IPO intraday trading strategy idea
Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $28,4;
take-profit — $38,12
stop-loss — $25,16
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
GBIO is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Generation Bio is an innovative genetic medicine company creating a new class of gene therapy.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $23,31;
take-profit — $28,53;
stop-loss — $21,57.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Houston Is There A Problem? - Nikola (NKLA)No discounting the fact that early buyers SHOULD BE doing the Scrooge McDuck dive in their gold coin swimming pools right now. But after looking through the hype, is there a true, near-term catalyst here? Is this a moon launch or just the top end of a bungee jump? Just a look at the filings raises some really good questions.
“Even if we are able to successfully develop and sell or lease our trucks, there can be no assurance that they will be commercially successful. Our potential profitability is dependent upon the successful development and successful commercial introduction and acceptance of our trucks and our hydrogen station platform, which may not occur.”
Quote Source: Is Nikola Corp (NKLA) An Overpriced Penny Stock Or The Real Deal?
Shift Payments Strong Buy --> IPO Scheduled TomorrowFirst off, please don't take anything I say seriously or as financial advice. As always, everything I say is on an opinion based basis. If anybody is excited for some potential IPO opportunities, Shift payments definitely looks like one of them. The price proposed at at $21, seems reasonable when looking at A) Competitors such as PayPal and Square B) Recent POS growth for restaurants post-Covid C) Financial expectancies. After missing the ZI IPO, I definitely think this one is one to watch out for + potentially hold. If it doubles, and I were to buy it than, I would sale and reinvest in the dip or hold depending on market activity. Either way, looks to be a strong buy.
I Missed a Huge IPO Opportunity, Feeling Dumb Right Now :(First off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, imagine having a chance to buy a stock at a $13 price point and doing a sell of for $42 within a day's time period. Had the chance to do that, and didn't. Didn't even get the stock. When you see a stock going down few hours Post-IPO, it is because many people are putting sell orders quick for profits and lots of activity happening during those time periods. Unfortunately, it can mess with your confidence and your judgement where you miss a great buy opportunity. I seen the stock's symbol from TradingView. It had hype. Now, I feel sick :(
NTO Nitro Software LimitedThe Next Docusign and runnerup to Adobe has recently been offered on the ASX, Price will most likely retrace to 1.53 or even test but not stay at 1.47.
The STC oscilator may reach 0 before the next leg of going long. ASX:NTO
003 PIGGISH PLAY - ER Long - CRWD - Enter Post-Retracement $66003. Piggish Play - CRWD ER Long
- Company is a strong, recent IPO
- Sector is hot, IPOs are hotter, ER whisper vs. consensus is very positive
- Chart is rare because it is a very bullish 2019 IPO with a perfect Fib-fitting in place already
- Usually recent IPOs can be difficult to play, but this one had the Corona-luck of drawing out key areas
-Instructions are in chart for how I''m playing it.***
**Will not be entering until broader market correction lightens in volatility.
***Alternative Entry if it does not retrace all the way to $66 week before earnings: Downward Approach + Hold $70
Piggish Rating: 92/100 because it is an unproven IPO, after all.
NASDAQ:CRWD
VTIQ merger to become NKLA!!!www.tradingview.com
VectoIQ Acquisition Corp. Common Stock, also called VectoIQ, is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus on searching for prospective target businesses to acquire.
This is a very popular pick up and has been a confirm on the rumors that VTIQ will become the public IPO of NKLA ( Nikola ) NASDAQ:TSLA only Competitor in the market. They will be continuing to climb until June 3rd when they switch the IPO over to NKLA and your shares will be transferred over the price it is at when they switch.
My suggestion is to continuously roll up your contracts in case of reverse stock split even though i'm waiting back to hear if this is going back to happen. Looks to gain about 25- 32% everyday!
- GC MAGIC OVERLAY is starting to split even more on the 1 hr time frame signaling very high momentum.
- STOCASTIC RSI is signaling over sold but that's stating the obvious.
- MACD has had 2 small red candles in 3 days.
- % TARGET to be estimated to hit around the $36+ strike might take a dip for a good entry around the current R4 support line
Going Long Slack aka WORKIn my opinion this one looks like it's about to breakout above $30 to head to it's original IPO price. Look for tech laggards to gain some momentum while the huge caps in tech to flatten out in my opinion.
Not trading advice, my opinions only.
WORK
🛢 OIL PUMP, SURPRISE OR 👁aluminati 👁 PLAN 🛢Hello people! 👁
Impact of oil price to our lives is hard to underestimate.
Today I’ve noticed hard pump of it's price and you can see we in $30-$20 price trading range.
This range could be a possible mid-term bottom for Oil.
But this is not all time bottom, IMHO.
I think we going to see $30 price this year.
What after $30? I can only imagine.
$20 again? Possible
Last year in December Aramco sold shares on biggest IPO in history and this is key highlight to me that oil prices are going to decline within next 5-10 years.
This is my personal opinion and you can think differently, I accept it.
Let me know your global vision for oil in our lives, please, write in comments.
Stay tuned to Artem Crypto
Uber Is About to Have a Golden CrossRide-sharing company Uber Technologies has had bad times and good times since its IPO last May. First, it had to cut its offer price. Then it fell all the way down to the mid-20s as investors worried about its profitability and sprawling operations.
But one by one, CEO Dara Khosrowshahi has moved to address those issues. He's exited non-core businesses and focused on making money. As a result, UBER was able to move forward its profitability goal the last time it reported earnings on February 6.
The stock gapped higher at the time, but then coronavirus came along and smashed it down to where it began 2020.
Meanwhile, enough time has passed for UBER's 200-day simple moving average (SMA) to appear. And guess what? Its 50-day SMA is about to rise up through the 200-day SMA. A "Golden Cross," could potentially occur in the next 1-2 sessions.
Another pattern on the chart is a tight ascending triangle since last Thursday. UBER's made incrementally higher lows while pushing against resistance at $34. That could be a potential trigger level for traders looking to hail a ride on the stock.